Filing Details

Accession Number:
0001104659-12-050211
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-20 19:10:49
Reporting Period:
2012-07-18
Filing Date:
2012-07-20
Accepted Time:
2012-07-20 19:10:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251618 P Guy Marsh 1172 Castro Street
Mountain View CA 94040
Vp, Operations And General Mgr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-18 9,108 $6.05 11,182 No 4 M Direct
Common Stock Disposition 2012-07-18 9,108 $30.36 2,074 No 4 S Direct
Common Stock Acquisiton 2012-07-18 3,444 $4.23 5,518 No 4 M Direct
Common Stock Disposition 2012-07-18 3,444 $30.36 2,074 No 4 S Direct
Common Stock Acquisiton 2012-07-18 23,639 $4.23 25,713 No 4 M Direct
Common Stock Disposition 2012-07-18 23,639 $30.36 2,074 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2012-07-18 3,444 $0.00 3,444 $4.23
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-07-18 23,639 $0.00 23,639 $4.23
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-07-18 9,108 $0.00 9,108 $6.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,301 2019-01-23 No 4 M Direct
3,617 2019-01-23 No 4 M Direct
0 2018-01-25 No 4 M Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2012.
  2. Twenty-five percent (25%) of the total number of shares became exercisable on 1/23/2010 and one forty-eighth (1/48th) of the total number of shares become exercisable at the end of each full month thereafter until the option is fully vested on 1/23/2013.
  3. This option is fully vested and immediately exercisable.